EFTA01358054.pdf

From: Daniel Sa Sent: 6/4/2015 12:06:59 PM To: Stewart Oldfield j; Vahe Stepanian Ariane Dwyer CC: Paul Morris Subject: Re: send to rich please ICI Classification: Confidential This is a good idea. Let's discuss. From: Stewart Oldfield Sent: Thursday, June 04, 2015 10:32 AM To: Daniel Sabba; Vahe Stepanian; Ariane Dwyer Cc: Paul Morris Subject: RE: send to rich please [C] Classification: Confidential Give me a quick call on this if you can. We had a client at CS who would send weekly lists of a few stocks he liked and we developed a consistent business around some worst-of pairs structures that may show a higher yield than JE's usual swap +covered call From: Paul Morris Sent: Tuesday, June 02, 2015 9:35 AM To: Ariane Dwyer Cc: Stewart Oldfield; Vahe Stepanian Subject: Re: send to rich please [C] Classification: Confidential Thx pls cc stew in future From: Mane Dwyer Sent: Tuesday, June 02, 2015 09:23 AM To: [email protected]. <[email protected]>; Cc: Vahe Stepanian; Daniel Sabba; Paul Morris Subject: RE: send to rich please [C] Classification: Confidential Good morning, Per your request, please find below the stocks with 6/1/15 close price, DB Global Market Research Rating and DB Global Market Research Target price. In addition please find attached DB Global Market Research Reports about the companies we cover. Please note these are independent equity research views. Price @ DB Global Markets DB Global Markets Company Ticker 6/1/15 Close Research Rating Research Target Retrophin RTRX $31.85* Buy $52 Orexigen Therapeutics OREX $4.91 No Coverage CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0045374 CONFIDENTIAL SDNY_GM_00191558 EFTA01358054